Pressure BioSciences, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Convertible Debt and Other Debt (Tables)

Convertible Debt and Other Debt (Tables)

9 Months Ended

Sep. 30, 2017

Schedule of Convertible Debts and Outstanding Balances

The specific terms of the convertible debts and outstanding balances as of September 30, 2017 are listed in the table below.

Inception Date	Term	Loan Amount		Outstanding Balance		Original Issue Discount			Interest Rate			Deferred Finance Fees		Discount related to fair value of conversion feature and warrants/shares
July 22, 2015	30 months¹	$	2,180,000	$	2,180,000	$	218,000	²		10	%³	$	388,532	$	2,163,074
September 25, 2015	30 months¹		1,100,000		1,100,000		110,000	²		10	%³		185,956		1,022,052
October 2, 2015	30 months¹		150,000		150,000		15,000	²		10	%³		26,345		140,832
October 6, 2015	30 months¹		30,000		30,000		3,000	²		10	%³		5,168		26,721
October 14, 2015	30 months¹		50,000		50,000		5,000	²		10	%³		8,954		49,377
November 2, 2015	30 months¹		250,000		250,000		25,000	²		10	%³		43,079		222,723
November 10, 2015	24 months		50,000		50,000		5,000	²		10	%³		8,790		46,984
November 12, 2015	24 months		215,000		215,000		21,500	²		10	%³		38,518		212,399
November 20, 2015	24 months		200,000		200,000		20,000	²		10	%³		37,185		200,000
December 4, 2015	24 months		170,000		170,000		17,000	²		10	%³		37,352		170,000
December 11, 2015	24 months		360,000		360,000		36,000	²		10	%³		75,449		360,000
December 18, 2015	24 months		55,000		55,000		5,500	²		10	%³		11,714		55,000
December 31, 2015	24 months		100,000		100,000		10,000	²		10	%³		20,634		100,000
January 11, 2016	24 months		100,000		100,000		10,000	²		10	%³		24,966		80,034
January 20, 2016	24 months		50,000		50,000		5,000	²		10	%³		9,812		40,188
January 29, 2016	24 months		300,000		300,000		30,000	²		10	%³		60,887		239,113
February 26, 2016	24 months		200,000		200,000		20,000	²		10	%³		43,952		156,048
March 10, 2016	24 months		125,000		125,000		12,500	²		10	%³		18,260		106,740
March 18, 2016	24 months		360,000		360,000		36,000	²		10	%³		94,992		265,008
March 24, 2016	24 months		106,667		106,667		10,667	²		10	%³		15,427		91,240
March 31, 2016	24 months		177,882		177,882		17,788	²		10	%³		2,436		175,446
June 15, 2016	6 months		40,000		-		-			12	%		-		3,680
June 17, 2016	6 months		40,000		-		-			12	%		-		3,899
June 22, 2016	6 months		35,000		-		-			12	%		-		3,373
July 6, 2016	6 months		85,000		-		-			12	%		-		15,048
July 29, 2016	6 months		100,000		-		-			12	%		-		25,518
September 15, 2016	8 months		500,000		-		85,541			9	%		-		65,972
April 3, 2017	8 months		50,000		-		-			10	%		-		-

		$	7,179,549	$	6,329,549	$	718,496					$	1,158,408	$	6,040,469

Summary of Changes in Convertible Debt, Net of Unamortized Discounts

The following table provides a summary of the changes in convertible debt and revolving note payable, net of unamortized discount, during 2017:

	2017
Balance at January 1,	$	5,273,937
Adjustment due to ASU 2017-11		923,468
Issuance of convertible debt, face value		2,300,000
Forgiveness of Debt		(50,000	)
Deferred financing cost		(180,000	)
Debt discount related to one-time interest charge		(225,000	)
Debt discount from incentive shares to increase the Revolving Note aggregate principal limit		(150,000	)
Debt discount from shares and warrants issued with the notes		(668,544	)
Payments		(840,541	)
Accretion of interest and amortization of debt discount to interest expense through September 30,		3,322,736
Balance at September 30,		9,706,056
Less: current portion		9,706,056
Convertible debt, long-term portion	$	-